Efficacy of canakinumab in biologic-naïve versus previously biologic-exposed SJIA patients: a 12 week pooled post-hoc analysis
Crossref DOI link: https://doi.org/10.1186/1546-0096-12-S1-P66
Published Online: 2014-09-17
Published Print: 2014-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Quartier, P
Grom, A
Ruperto, N
Brunner, HI
Schikler, K
Erguven, M
Goffin, L
Hofer, M
Kallinich, T
Marzan, K
Gaillez, C
Lheritier, K
Abrams, K
Martini, A
Lovell, DJ
Article History
First Online: 17 September 2014